Lorcaserin alters serotonin and noradrenaline tissue content and their interaction with dopamine in the rat brain
G Di Giovanni, R Bharatiya, E Puginier… - Frontiers in …, 2020 - frontiersin.org
Lorcaserin is a preferential serotonin2C receptor (5-HT2CR) agonist effective to treat obesity
that has also recently been proposed to treat addiction and epilepsy. Central dopamine (DA) …
that has also recently been proposed to treat addiction and epilepsy. Central dopamine (DA) …